Multinational case-control study of risk factors for the development of late invasive pulmonary aspergillosis following kidney transplantation

Autor: López-Medrano, F, Fernández-Ruiz, M, Silva, J T, Carver, P L, van Delden, C, Merino, E, Pérez-Saez, M J, Montero, M, Coussement, J, de Abreu Mazzolin, M, Cervera, C, Santos, L, Sabé, N, Scemla, A, Cordero, E, Cruzado-Vega, L, Martín-Moreno, P L, Len, Ó, Rudas, E, Ponce de León, A, Arriola, M, Lauzurica, R, David, M D, González-Rico, C, Henríquez-Palop, F, Fortún, J, Nucci, M, Manuel, O, Paño-Pardo, J R, Montejo, M, Vena, A, Sánchez-Sobrino, B, Mazuecos, A, Pascual, J, Horcajada, J P, Lecompte, T, Moreno, A, Carratalà, J, Blanes, M, Hernández, D, Hernández-Méndez, E A, Fariñas, M C, Perelló-Carrascosa, M, Muñoz, P, Andrés, A, Aguado, J M, Spanish Network for Research in Infectious Diseases (REIPI), Group for the Study of Infection in Transplant Recipients (GESITRA) of the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC), Study Group for Infections in Compromised Hosts (ESGICH) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Swiss Transplant Cohort Study (STCS)
Přispěvatelé: Van Delden, Christian, Spanish Network for Research in Infectious Diseases (REIPI), Group for the Study of Infection in Transplant Recipients (GESITRA) of the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC), Study Group for Infections in Compromised Hosts (ESGICH) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Swiss Transplant Cohort Study (STCS), Universitat de Barcelona
Jazyk: angličtina
Rok vydání: 2017
Předmět:
0301 basic medicine
Male
Respiratory diseases
Aspergil·losi
Time Factors
Trasplantament renal
030230 surgery
Global Health
Kidney transplantation
0302 clinical medicine
skin and connective tissue diseases
ddc:616
Invasive Pulmonary Aspergillosis
case-control study
kidney transplantation
late invasive pulmonary aspergillosis
risk factors
Case-control study
Late invasive pulmonary aspergillosis
Risk factors
Factors de risc en les malalties
Kidney Transplantation/adverse effects
Invasive Pulmonary Aspergillosis/etiology
General Medicine
Middle Aged
Infectious Diseases
Female
Microbiology (medical)
medicine.medical_specialty
Tuberculosis
Risk factors in diseases
030106 microbiology
Pulmonary disease
Ronyons -- Trasplantació
Malalties de l'aparell respiratori
03 medical and health sciences
Internal medicine
medicine
Aspergillosis
Humans
De novo malignancy
Retrospective Studies
business.industry
Pulmons -- Malalties
Invasive pulmonary aspergillosis
bacterial infections and mycoses
medicine.disease
Kidney Transplantation
respiratory tract diseases
Surgery
Global Health/statistics & numerical data
Transplantation
Pneumonia
Case-Control Studies
business
Zdroj: Recercat. Dipósit de la Recerca de Catalunya
instname
Dipòsit Digital de la UB
Universidad de Barcelona
Clinical Microbiology and Infection, Vol. 24, No 2 (2018) pp. 192-198
Clinical Microbiology and Infection
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
CLINICAL MICROBIOLOGY AND INFECTION
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
Clinical microbiology and infection, vol. 24, no. 2, pp. 192-198
r-FISABIO. Repositorio Institucional de Producción Científica
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
ISSN: 1198-743X
Popis: To assess the risk factors for development of late-onset invasive pulmonary aspergillosis (IPA) after kidney transplantation (KT). We performed a multinational case-control study that retrospectively recruited 112 KT recipients diagnosed with IPA between 2000 and 2013. Controls were matched (1:1 ratio) by centre and date of transplantation. Immunosuppression-related events (IREs) included the occurrence of non-ventilator-associated pneumonia, tuberculosis, cytomegalovirus disease, and/or de novo malignancy. We identified 61 cases of late (>180 days after transplantation) IPA from 24 participating centres (accounting for 54.5% (61/112) of all cases included in the overall study). Most diagnoses (54.1% (33/61)) were established within the first 36 post-transplant months, although five cases occurred more than 10 years after transplantation. Overall mortality among cases was 47.5% (29/61). Compared with controls, cases were significantly older (p 0.010) and more likely to have pre-transplant chronic obstructive pulmonary disease (p 0.001) and a diagnosis of bloodstream infection (p 0.016) and IRE (p 180 days after transplantation) IPA from 24 participating centres (accounting for 54.5% (61/112) of all cases included in the overall study). Most diagnoses (54.1% (33/61)) were established within the first 36 post-transplant months, although five cases occurred more than 10 years after transplantation. Overall mortality among cases was 47.5% (29/61). Compared with controls, cases were significantly older (p 0.010) and more likely to have pre-transplant chronic obstructive pulmonary disease (p 0.001) and a diagnosis of bloodstream infection (p 0.016) and IRE (p More than half of IPA cases after KT occur beyond the sixth month, with some of them presenting very late. Late IPA entails a poor prognosis. We identified some risk factors that could help the clinician to delimit the subgroup of KT recipients at the highest risk for late IPA.
Databáze: OpenAIRE